Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
NIH seeks applications for a clinical trials network to evaluate interventions for emerging and chronic infections and support early-career investigators and those new to the field.
This grant was recently updated
This grant has transitioned from forecasted to posted and is now accepting applications.
Funder: National Institutes of Health
Due Dates: November 10, 2026 (Application, 5:00 PM applicant organization’s local time) | October 10, 2026 (Earliest submission)
Funding Amounts: Up to $450,000 in direct costs annually per CTEU, plus $2,000,000 in direct costs for an optional NCC; seven-year projects
Summary: Supports domestic clinical trial infrastructure and network coordination to evaluate interventions for emerging and chronic infectious diseases.
Key Information: Each application must propose one CTEU, and at least one PD/PI must hold an M.D. or D.O.
Description
The National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, supports the Infectious Diseases Clinical Trials Network through UM1 cooperative agreements. The network evaluates therapeutics, vaccines, biologics, diagnostics, and devices to treat and ultimately prevent emerging and chronic infections. Clinical Trial Evaluation Units (CTEUs) provide domestic infrastructure to design and implement clinical trials and studies, while a Network Coordination Center (NCC) provides scientific leadership and operational coordination.
The network’s Phase I–IV capabilities span malaria and neglected tropical diseases, sexually transmitted infections, respiratory infections—particularly influenza—enteric diseases, and emerging infections. Individual CTEUs need not cover every scientific area. Research may include preventive and therapeutic candidates, controlled human infection models, and diagnostic tools. The network also creates opportunities for early-career investigators and researchers new to the field.
